SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-21-143414
Filing Date
2021-11-24
Accepted
2021-11-24 11:42:39
Documents
1
Effectiveness Date
2021-11-24

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2133712d1_s8pos.htm S-8 POS 32305
  Complete submission text file 0001104659-21-143414.txt   33412
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-253396 | Film No.: 211443318
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences